n this issue: NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
Aspirin dose and cardioprotection; uncovering modafinil's abuse potential; proton-pump inhibitors and clopidogrel; FDA actions.
The need for participation of the primary care physician in the treatment of sleep apnea has become much more apparent in recent years.
Most type 2 diabetics (DM2) who undergo bariatric surgery enjoy a prompt reversal or at least a substantial diminution of their dysglycemia.
Use of statins as primary prevention in healthy people with elevated high-sensitivity C-reactive protein without hyperlipidemia may reduce the incidence of major cardiovascular events.
